Disturbed homeostasis of gut microbiota has been suggested to be closely associated with
5-fluorouracil (5-Fu) induced
mucositis. However, current knowledge of the overall profiles of 5-Fu-disturbed gut microbiota is limited, and so far there is no direct convincing evidence proving the causality between 5-Fu-disturbed microbiota and colonic
mucositis. In mice, in agreement with previous reports,
5-Fu resulted in severe colonic
mucositis indicated by
weight loss,
diarrhea, bloody stool, shortened colon, and infiltration of inflammatory cells. It significantly changed the profiles of inflammatory
cytokines/
chemokines in serum and colon. Adhesion molecules such as
vascular cell adhesion molecule-1 (VCAM-1),
intercellular adhesion molecule-1 (ICAM-1), and
VE-Cadherin were increased. While
tight junction protein occludin was reduced, however, zonula occludens-1 (ZO-1) and
junctional adhesion molecule-A (JAM-A) were increased in colonic tissues of
5-Fu treated mice. Meanwhile,
inflammation related signaling pathways including NF-κB and
mitogen activated protein kinase (MAPKs) in the colon were activated. Further study disclosed that
5-Fu diminished bacterial community richness and diversity, leading to the relative lower abundance of Firmicutes and decreased Firmicutes/Bacteroidetes (F/B) ratio in feces and cecum contents.
5-Fu also reduced the proportion of Proteobacteria, Tenericutes, Cyanobacteria, and Candidate division TM7, but increased that of Verrucomicrobia and Actinobacteria in feces and/or cecum contents. The
fecal transplant from healthy mice prevented
body weight loss and colon shortening of
5-Fu treated mice. In addition, the
fecal transplant from
5-Fu treated mice reduced
body weight and colon length of
vancomycin-pretreated mice. Taken together, our study demonstrated that gut microbiota was actively involved in the pathological process of
5-Fu induced intestinal
mucositis, suggesting potential attenuation of
5-Fu induced intestinal
mucositis by manipulating gut microbiota homeostasis.